Publications by authors named "Vijay Ahuja"

20Publications

Minimally Invasive Surgery and Surgical Smoke, Decoding Fear and Ensuring Safety: Adaptations and Safety Modifications During COVID Pandemic.

Indian J Gynecol Oncol 2020 18;18(3):96. Epub 2020 Aug 18.

Department of Surgical and Gynecological Oncology, Manipal Comphrensive Cancer Centre, Manipal Hospital, Old Airport Road, Rustum Bagh, Bangalore, 560 017 India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40944-020-00443-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432460PMC
August 2020

Impact of extent of parietal peritonectomy on oncological outcome after cytoreductive surgery and HIPEC.

Pleura Peritoneum 2019 Dec 6;4(4):20190015. Epub 2019 Nov 6.

Department of Surgical Oncology, Manipal Comprehensive Cancer Centre, Manipal Hospital, Bengaluru India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/pp-2019-0015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881664PMC
December 2019

Discovery of Pyridazinone and Pyrazolo[1,5-]pyridine Inhibitors of C-Terminal Src Kinase.

ACS Med Chem Lett 2019 Oct 25;10(10):1486-1491. Epub 2019 Sep 25.

Bristol-Myers Squibb Company, Research and Development, Route 206 and Province Line Road, Princeton, New Jersey 08543, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acsmedchemlett.9b00354DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6792176PMC
October 2019

Synthesis and evaluation of prodrugs of corticotropin-releasing factor-1 (CRF) receptor antagonist BMS-665053 leading to improved oral bioavailability.

Bioorg Med Chem Lett 2017 03 10;27(6):1360-1363. Epub 2017 Feb 10.

Research and Development, Bristol-Myers Squibb Company, 5 Research Parkway, Wallingford, CT 06492, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2017.02.015DOI Listing
March 2017

Synthesis and evaluation of carbamate and aryl ether substituted pyrazinones as corticotropin releasing factor-1 (CRF₁) receptor antagonists.

Bioorg Med Chem Lett 2016 May 17;26(9):2184-7. Epub 2016 Mar 17.

Bristol-Myers Squibb Co., Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2016.03.067DOI Listing
May 2016

Potential CRF1R PET imaging agents: 1-fluoroalkylsubstituted 5-halo-3-(arylamino)pyrazin-2(1H)-ones.

Bioorg Med Chem Lett 2013 Apr 13;23(7):2052-5. Epub 2013 Feb 13.

Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2013.02.009DOI Listing
April 2013

Chiral separation of potent corticotropin-releasing factor-1 receptor antagonists by supercritical fluid chromatography.

J Pharm Biomed Anal 2011 Feb 30;54(3):602-6. Epub 2010 Oct 30.

Bristol-Myers Squibb Co., Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpba.2010.09.031DOI Listing
February 2011

Synthesis and structure-activity relationships of N3-pyridylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists.

Bioorg Med Chem Lett 2010 Mar 1;20(6):1890-4. Epub 2010 Feb 1.

Neuroscience Discovery Chemistry, Research and Development, Bristol-Myers Squibb Company, Wallingford, CT 06492, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2010.01.129DOI Listing
March 2010

Evaluation of outcome of various treatment methods for endogenous endophthalmitis.

Indian J Med Sci 2006 Nov;60(11):454-60

National Institute of Ophthalmology, Pune, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/0019-5359.27972DOI Listing
November 2006

Design, synthesis, and biological evaluation of 1,2,3,7-tetrahydro-6h-purin-6-one and 3,7-dihydro-1h-purine-2,6-dione derivatives as corticotropin-releasing factor(1) receptor antagonists.

J Med Chem 2004 Sep;47(19):4741-54

Discovery Chemistry, Neuroscience Biology, and Metabolism and Pharmacokinetics, Bristol-Myers Squibb Company, Pharmaceutical Research Institute, 5 Research Parkway, Wallingford, Connecticut 06492, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/jm049787kDOI Listing
September 2004